机译:用新辅助化疗和自由基膀胱切除术治疗肌肉侵袭性膀胱癌患者中性粒细胞对淋巴细胞比的预后价值
Univ British Columbia Dept Urol Sci Vancouver BC Canada;
Univ British Columbia Dept Urol Sci Vancouver BC Canada;
H Lee Moffitt Canc Ctr &
Res Inst Dept Genitourinary Oncol Tampa FL USA;
Univ Alberta Edmonton AB Canada;
Antoni van Leeuwenhoek Hosp Dept Urol Netherlands Canc Inst Amsterdam Netherlands;
MD Anderson Canc Ctr Dept Urol Houston TX USA;
Cleveland Clin Glickman Urol &
Kidney Inst Cleveland OH 44106 USA;
Univ Texas Southwestern Med Ctr Dallas Dept Urol Dallas TX 75390 USA;
Univ Oklahoma Coll Med Dept Urol Oklahoma City OK 73190 USA;
Univ Alberta Edmonton AB Canada;
Univ Kansas Med Ctr Dept Urol Kansas City KS 66103 USA;
Univ Michigan Hlth Syst Dept Urol Ann Arbor MI USA;
Lister Hosp Hertfordshire &
Bedfordshire Urol Canc Ctr Dept Urol Stevenage Herts England;
Univ Washington Dept Med Div Oncol Sch Med Seattle WA 98195 USA;
Presbyterian Hosp Weill Cornell Med Coll Dept Urol New York NY USA;
Royal Devon &
Exeter NHS Trust Exeter Surg Hlth Serv Res Unit Exeter Surg Hlth Serv Dept Surg;
McGill Univ Hlth Ctr Div Urol Dept Surg Montreal PQ Canada;
Univ Calif Davis Davis Med Ctr Dept Urol Sacramento CA 95817 USA;
Princess Margaret Hosp Toronto ON Canada;
Cleveland Clin Glickman Urol &
Kidney Inst Cleveland OH 44106 USA;
Antoni van Leeuwenhoek Hosp Dept Urol Netherlands Canc Inst Amsterdam Netherlands;
Royal Devon &
Exeter NHS Trust Exeter Surg Hlth Serv Res Unit Exeter Surg Hlth Serv Dept Surg;
Royal Devon &
Exeter NHS Trust Exeter Surg Hlth Serv Res Unit Exeter Surg Hlth Serv Dept Surg;
Presbyterian Hosp Weill Cornell Med Coll Dept Urol New York NY USA;
Univ Washington Dept Urol Seattle WA 98195 USA;
Freeman Rd Hosp Dept Urol Newcastle Upon Tyne Tyne &
Wear England;
Univ Michigan Hlth Syst Dept Urol Ann Arbor MI USA;
Univ Kansas Med Ctr Dept Urol Kansas City KS 66103 USA;
Johns Hopkins Sch Med James Buchanan Brady Urol Inst Dept Urol Baltimore MD USA;
Cross Canc Inst Edmonton AB Canada;
Vanderbilt Univ Med Ctr Dept Urol Surg Nashville TN USA;
Univ Texas Southwestern Med Ctr Dallas Dept Urol Dallas TX 75390 USA;
Univ Washington Dept Med Div Oncol Sch Med Seattle WA 98195 USA;
Cleveland Clin Glickman Urol &
Kidney Inst Cleveland OH 44106 USA;
MD Anderson Canc Ctr Dept Urol Houston TX USA;
Antoni van Leeuwenhoek Hosp Dept Urol Netherlands Canc Inst Amsterdam Netherlands;
H Lee Moffitt Canc Ctr &
Res Inst Dept Genitourinary Oncol Tampa FL USA;
Univ Southern Calif Inst Urol USC Norris Comprehens Canc Ctr Los Angeles CA 90007 USA;
Princess Margaret Hosp Toronto ON Canada;
Univ British Columbia Dept Urol Sci Vancouver BC Canada;
MIBC; NLR; Neoadjuvant chemotherapy; Urothelial carcinoma; Radical cystectomy;
机译:用新辅助化疗和自由基膀胱切除术治疗肌肉侵袭性膀胱癌患者中性粒细胞对淋巴细胞比的预后价值
机译:Re:低预处理中性粒细胞到淋巴细胞比率预测接受Neoadjuvant化疗前的良好结果,以便在激进的膀胱切除术前肌肉侵袭性膀胱切除术治疗
机译:中性粒细胞与淋巴细胞比率的预后价值以及新型膀胱癌根治性膀胱切除术患者术前风险分层模型的建立
机译:肌肉浸润性膀胱癌新辅助化疗反应的预测性生物标志物:一项调查
机译:增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
机译:编程死亡配体-1对肿瘤浸润性免疫细胞对肌肉侵袭性膀胱切除术治疗的患者肿瘤浸润免疫细胞表达的预后价值:肌肉侵袭性膀胱癌:回顾性队列研究
机译:MP26-17可能是非肌肉侵袭性膀胱癌的历史在CT2-4AN0M0膀胱癌患者中具有预后作用,治疗自由基膀胱切除术和Neoadjuvant化疗进行治疗吗?